|
|
|
|
|
|
by marc__1
1883 days ago
|
|
|
There are some very interesting nuggets from their IPO prospectus, which if misleading could eventually turn to 'securities fraud' [1] [2] > Approximately 74% of Darktrace’s trial deployments in 2020 detected serious vulnerabilities that very often had evaded other defences and quickly demonstrate to prospective customers the comprehensive nature of the AI driven technology. >The Cyber AI Platform’s average set up time is one hour and the machine learning gains visibility through software sensors that analyse raw, real-time data. >The Enterprise Immune System and Industrial Immune System use self-learning AI technology to spot the subtle signals of sophisticated attacks and do not rely on traditional rules and signatures to help detect attacks and defend against them. The Cyber AI Analyst product augments human cyber security teams, by automatically triaging, interpreting and reporting on security incidents. The Directors believe Darktrace Antigena is the first solution to use autonomous response to interrupt detected attacks [1] https://ir.darktrace.com
[2] https://www.bloomberg.com/opinion/articles/2019-06-26/everyt... |
|
|